Filing Flows › Comparisons › NRC vs FOXO
NRC Health vs Foxo Technologies: NRC and FOXO compared
NRC Health is the larger company: $38.4M of revenue in its latest quarter (Q3 2026) against $4.7M for Foxo Technologies (Q2 2026). NRC Health is growing faster (+11% against -10% a year earlier). Foxo Technologies is more profitable, with an operating margin of 185.5% against 23.2%.
Where the money goes: NRC and FOXO
NRC Health (NRC) · Q3 2026
NRC Health, Q3 2026: revenue $38.4M (+11% year over year), operating margin 23.2%, net earnings $4.7M, operating cash flow $8.0M. The chart follows the revenue to costs, profit and cash.
Foxo Technologies (FOXO) · Q2 2026
Foxo Technologies, Q2 2026: revenue $4.7M (-10% year over year), operating margin 185.5%, net earnings $8.1M, operating cash flow $299K. The chart follows the revenue to costs, profit and cash.
| NRC Health (NRC) | Foxo Technologies (FOXO) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $38.4M | $4.7M |
| Revenue growth, Y/Y | +11% | -10% |
| Operating margin | 23.2% | 185.5% |
| Net earnings | $4.7M | $8.1M |
| Net margin | 12.3% | 172.6% |
| Operating cash flow | $8.0M | $299K |
| Free cash flow | $7.0M | $293K |
Where the revenue comes from
Foxo Technologies
- Health Cares: $4.5M (95%)
- Life Science Services: $238K (5%)
- Labs: $6K (0%)
Questions
Which is bigger, NRC Health or Foxo Technologies?
NRC Health is the larger company: $38.4M of revenue in its latest quarter (Q3 2026) against $4.7M for Foxo Technologies (Q2 2026).
Is NRC Health or Foxo Technologies growing faster?
NRC Health is growing faster (+11% against -10% a year earlier).
Which is more profitable, NRC Health or Foxo Technologies?
Foxo Technologies is more profitable, with an operating margin of 185.5% against 23.2%.
More: NRC Health earnings · how NRC Health makes money · Foxo Technologies earnings · how Foxo Technologies makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.